hey @TimmyR30 perhaps novartis is just waiting on read outs on the many biomarkers before re-committing to this indication ...SI has not said they are giving up on Covid Ards...

yes novartis collaboration /partnership looks like focus is switching to non-covid ards but if results of our covid ards are promising there is always a chance we could see some sort of emergency approval...( afterall covid is not going away anytime soon)

A Non-covid ards trial if successful, could also open up the covid ards market via a label extension and we would have a more consistant cohort of patients ( as opposed to rapidly changing cohort during our recent trials ford covid ards)

but i will not right off our chances for an eventual approval in covid ards ....